Equities

Dr. Lal PathLabs Ltd

LALPATHLAB:NSI

Dr. Lal PathLabs Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)2,956.40
  • Today's Change-1.90 / -0.06%
  • Shares traded149.23k
  • 1 Year change+12.71%
  • Beta0.7514
Data delayed at least 15 minutes, as of Nov 14 2024 10:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income3,6232,4113,503
Depreciation/depletion1,4361,5021,081
Non-Cash items1,2571,3571,350
Cash taxes paid, supplemental1,3201,0641,300
Cash interest paid, supplemental294377304
Changes in working capital(963)(710)(1467)
Total cash from operations5,3534,5604,467
INVESTING
Capital expenditures(574)(446)(4761)
Other investing and cash flow items, total332(2427)269
Total cash from investing(243)(2873)(4492)
FINANCING
Financing cash flow items(294)(379)(304)
Total cash dividends paid(2012)(1030)(1167)
Issuance (retirement) of stock, net358.721.38
Issuance (retirement) of debt, net(1868)(1432)2,834
Total cash from financing(4139)(2832)1,365
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash972(1145)1,339
Net cash-begin balance/reserved for future use2,6373,7822,443
Net cash-end balance/reserved for future use3,6092,6373,782
SUPPLEMENTAL INCOME
Depreciation, supplemental1,4361,5021,081
Cash interest paid, supplemental294377304
Cash taxes paid, supplemental1,3201,0641,300
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.